Trial ID: | L4248 |
Source ID: | NCT06293417
|
Associated Drug: |
Ezetimibe/Fenofibrate (Ezefeno) And Moderate-Intensity Statin
|
Title: |
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
|
Acronym: |
ENSEMBLE
|
Status: |
RECRUITING
|
Study Results: |
NO
|
Results: |
|
Conditions: |
T2DM (Type 2 Diabetes Mellitus)|Dyslipidemias
|
Interventions: |
DRUG: Ezetimibe/fenofibrate (Ezefeno) and moderate-intensity statin|DRUG: Dose escalation of moderate-intensity statin
|
Outcome Measures: |
Primary: major adverse cardiovascular events and diabetic microvascular events for 48 months, major adverse cardiovascular events and diabetic microvascular events for 48 months, 48month from baseline | Secondary: proportion of patients achieving Non-HDL-C less than 100mg/dL, proportion of patients achieving Non-HDL-C less than 100mg/dL, 48month from baseline|proportion of patients achieving LDL less than 70mg/dL, proportion of patients achieving LDL less than 70mg/dL, 48month from baseline|change in Non-HDL-C at 48month from baseline, change in Non-HDL-C at 48month from baseline, 48month from baseline|change in LDL at 48month from baseline, change in LDL at 48month from baseline, 48month from baseline|change in HDL-C at 48month from baseline, change in HDL-C at 48month from baseline, 48month from baseline|change in TG at 48month from baseline, change in TG at 48month from baseline, 48month from baseline|change in LDL-C/HDL-C ratio at 48month from baseline, change in LDL-C/HDL-C ratio at 48month from baseline, 48month from baseline|change in TC/HDL-C ratio at 48month from baseline, change in TC/HDL-C ratio at 48month from baseline, 48month from baseline
|
Sponsor/Collaborators: |
Sponsor: Korea University Anam Hospital
|
Gender: |
ALL
|
Age: |
ADULT, OLDER_ADULT
|
Phases: |
|
Enrollment: |
3958
|
Study Type: |
INTERVENTIONAL
|
Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
Start Date: |
2024-03-01
|
Completion Date: |
2027-02-01
|
Results First Posted: |
|
Last Update Posted: |
2024-08-27
|
Locations: |
Korea University Anam Hospital, Seoul, Korea, Republic of
|
URL: |
https://clinicaltrials.gov/show/NCT06293417
|